Keerthi Gogineni

CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment

Angela DeMichele, Amy S. Clark, Kay See Tan et al. · Clinical Cancer Research · 2014 · 348 citations

Medicine, Oncology, Pharmacology +17

US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials

Jeanne M. Regnante, Nicole Richie, Lola A. Fashoyin‐Aje et al. · Journal of Oncology Practice · 2019 · 92 citations · Full text

Medicine, Oncology, Cancer Control +16

Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer

Alyssa N. Troeschel, Yuan Liu, Lindsay J. Collin et al. · International Journal of Epidemiology · 2019 · 55 citations · Full text

Medicine, Biostatistics, Oncology +17

Association of Race and Area Deprivation With Breast Cancer Survival Among Black and White Women in the State of Georgia

Justin M. Luningham, Gaurav Seth, Geetanjali Saini et al. · JAMA Network Open · 2022 · 55 citations · Full text

Public Health, Oncology, Population Health Sciences +17

Patient Demands and Requests for Cancer Tests and Treatments

Keerthi Gogineni, Katherine Shuman, Derek Chinn et al. · JAMA Oncology · 2015 · 51 citations

Medicine, Oncology, Clinical Medicine +12